| Fiscal period | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|
| Period End Date | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | 12/31/2011 |
|---|
| Sales | 1,229.22 | 1,249.13 | 1,213.99 | 1,054.20 | 942.16 | 848.90 | 890.65 | 826.85 | 633.81 | 635.25 |
| Total Revenues | 1,229.22 | 1,249.13 | 1,213.99 | 1,054.20 | 942.16 | 848.90 | 890.65 | 826.85 | 633.81 | 635.25 |
| Cost of goods sold | 798.09 | 783.32 | 778.71 | 697.43 | 655.24 | 600.32 | 613.37 | 589.01 | 472.22 | 441.55 |
| Gross Profit | 431.12 | 465.81 | 435.28 | 356.78 | 286.92 | 248.58 | 277.28 | 237.84 | 161.59 | 193.70 |
| Impairment of goodwill | -- | -- | -- | -- | -- | -- | -- | 5.32 | 0.00 | 0.00 |
| Amortization of acquisition-related intangible assets | 16.26 | 18.04 | 18.35 | 18.80 | 20.48 | 8.60 | 7.91 | 8.08 | 5.12 | 4.50 |
| Research and development expenses | 94.29 | 88.52 | 86.29 | 77.88 | 69.94 | 57.03 | 52.14 | 48.30 | 33.76 | 27.23 |
| In-process research and development | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Selling and general administrative expenses | 185.07 | 181.34 | 176.20 | 168.59 | 158.32 | 139.25 | 133.70 | 132.11 | 101.36 | 89.97 |
| Restructuring charge | -- | -- | -- | 10.14 | 0.01 | -- | -- | 1.54 | 0.00 | 0.00 |
| Impairment of long-lived assets | -- | -- | -- | (2.21) | (0.11) | (1.67) | -- | -- | -- | -- |
| Other operating income (Expenses) | (1.07) | (1.73) | (0.60) | 0.00 | (0.07) | 0.06 | 0.98 | -- | -- | -- |
| Gain (Loss) on Sale of Assets | (0.11) | 24.43 | 0.64 | 0.25 | -- | -- | -- | (0.22) | 3.56 | -- |
| Total Operating Expenses | 296.79 | 265.20 | 280.79 | 277.37 | 248.93 | 206.48 | 192.77 | 195.56 | 136.69 | 121.71 |
| Income from operations | 134.33 | 200.61 | 154.48 | 79.41 | 37.99 | 42.10 | 84.51 | 42.28 | 24.90 | 71.99 |
| Interest expense | 11.66 | 7.89 | 9.90 | 13.45 | 13.26 | 4.23 | 4.33 | 5.58 | 0.88 | 3.14 |
| Impairment of cost-basis investment | -- | -- | -- | -- | 3.22 | -- | -- | -- | -- | -- |
| Loss on securities carried at fair value | -- | -- | -- | -- | -- | 0.40 | 1.36 | 0.60 | 7.10 | (1.04) |
| Interest income (expense), net | 1.07 | 2.19 | 1.98 | 1.48 | 1.36 | 1.01 | 1.47 | 1.27 | 0.78 | 1.02 |
| Other | 6.42 | 7.08 | 7.10 | 3.15 | (0.01) | 0.06 | 2.98 | 0.01 | (1.09) | 0.86 |
| Amortization of debt discount | -- | -- | -- | -- | -- | -- | -- | -- | -- | (6.03) |
| Foreign currency loss, net | (9.81) | (3.74) | (3.70) | (8.00) | 2.17 | 1.26 | -- | -- | -- | -- |
| Total other income (expenses) | (13.99) | (2.36) | (4.52) | (16.82) | (12.96) | (1.51) | 1.48 | (3.70) | 5.91 | (8.33) |
| Income before income taxes and noncontrolling interest | 120.34 | 198.25 | 149.96 | 62.59 | 25.04 | 40.60 | 85.99 | 38.59 | 30.81 | 63.66 |
| Current- Foreign | -- | -- | -- | -- | -- | -- | -- | -- | -- | 18.32 |
| Current: Federal | -- | -- | -- | -- | -- | -- | -- | -- | -- | 14.05 |
| Current: State | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.21 |
| Income tax (benefit) provision | 21.11 | 44.13 | 44.56 | 62.33 | 6.56 | 14.08 | 20.36 | 14.48 | 4.83 | 10.16 |
| Deferred: Federal | -- | -- | -- | -- | -- | -- | -- | -- | -- | (20.91) |
| Deferred: Foreign | -- | -- | -- | -- | -- | -- | -- | -- | -- | (1.17) |
| Deferred Tax | -- | -- | -- | -- | -- | -- | -- | -- | -- | (0.47) |
| Liability for unrecognized tax benefits | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Minority interest in joint venture earnings | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income(Loss) before Preferred Dividend & Noncontrolling Interest | 99.23 | 154.12 | 105.41 | 0.27 | 18.48 | 26.51 | 65.63 | 24.10 | 25.98 | 53.51 |
| Less net (income) loss attributable to noncontrolling interest | 1.14 | 0.87 | 1.39 | 2.07 | 2.54 | 2.24 | 1.96 | (2.43) | 1.83 | 2.77 |
| Net income attributable to common stockholders | 98.09 | 153.25 | 104.02 | (1.81) | 15.94 | 24.27 | 63.68 | 26.53 | 24.15 | 50.74 |
| Basic earnings per share attributable to common stockholders | 1.92 | 3.02 | 2.09 | (0.04) | 0.33 | 0.50 | 1.35 | 0.57 | 0.53 | 1.12 |
| Diluted earnings per share attributable to common stockholders | 1.88 | 2.96 | 2.04 | (0.04) | 0.32 | 0.49 | 1.31 | 0.56 | 0.51 | 1.09 |
| Basic number of shares used in computation | 51.00 | 50.79 | 49.84 | 48.82 | 48.60 | 48.21 | 47.18 | 46.36 | 45.78 | 45.20 |
| Diluted number of shares used in computation | 52.13 | 51.86 | 50.94 | 48.82 | 49.79 | 49.50 | 48.59 | 47.66 | 46.90 | 46.71 |